EP1169332A4 - 49 human sekrtierte proteine - Google Patents

49 human sekrtierte proteine

Info

Publication number: EP1169332A4
Authority: EP; European Patent Office
Prior art keywords: secreted proteins; human secreted; human; proteins; secreted
Prior art date: 1999-03-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP00912201A

Other languages

English (en)

French (fr)

Other versions

EP1169332A1 (de

Inventor

Craig A Rosen

Steven M Ruben

George Komatsoulis

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Human Genome Sciences Inc

Original Assignee

Human Genome Sciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-12

Filing date

2000-03-09

Publication date

2003-09-03

2000-03-09 Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc

2002-01-09 Publication of EP1169332A1 publication Critical patent/EP1169332A1/de

2003-09-03 Publication of EP1169332A4 publication Critical patent/EP1169332A4/de

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Oncology (AREA)
Immunology (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Vascular Medicine (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

EP00912201A 1999-03-12 2000-03-09 49 human sekrtierte proteine Withdrawn EP1169332A4 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US12414599P	1999-03-12	1999-03-12
US124145P		1999-03-12
US16865499P	1999-12-03	1999-12-03
US168654P		1999-12-03
PCT/US2000/006058 WO2000055177A2 (en)	1999-03-12	2000-03-09	49 human secreted proteins

Publications (2)

Publication Number	Publication Date
EP1169332A1 EP1169332A1 (de)	2002-01-09
EP1169332A4 true EP1169332A4 (de)	2003-09-03

Family

ID=26822250

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP00912201A Withdrawn EP1169332A4 (de)	1999-03-12	2000-03-09	49 human sekrtierte proteine

Country Status (5)

Country	Link
EP (1)	EP1169332A4 (de)
JP (1)	JP2002538811A (de)
AU (1)	AU3396600A (de)
CA (1)	CA2361277A1 (de)
WO (1)	WO2000055177A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002008288A2 (en) *	2000-07-20	2002-01-31	Genentech, Inc.	Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6730491B2 (en)	2000-02-29	2004-05-04	Millennium Pharmaceuticals, Inc.	2504, 15977, and 14760, novel protein kinase family members and uses therefor
US6893818B1 (en)	1999-10-28	2005-05-17	Agensys, Inc.	Gene upregulated in cancers of the prostate
US6461846B2 (en)	2000-05-30	2002-10-08	Pe Corporation	Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
AU6531101A (en) *	2000-06-02	2001-12-17	Genentech Inc	Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6911335B2 (en)	2001-03-16	2005-06-28	Millennium Pharmaceuticals, Inc.	57316 and 33338, human ubiquitin carboxyl terminal hydrolases and uses therefor
CN110542737B (zh) *	2019-10-23	2022-03-22	贵州缔谊健康制药有限公司	一种盐酸氟桂利嗪胶囊溶出测定的检测方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5536637A (en) *	1993-04-07	1996-07-16	Genetics Institute, Inc.	Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
WO1998054963A2 (en) *	1997-06-06	1998-12-10	Human Genome Sciences, Inc.	207 human secreted proteins

2000
- 2000-03-09 AU AU33966/00A patent/AU3396600A/en not_active Abandoned
- 2000-03-09 EP EP00912201A patent/EP1169332A4/de not_active Withdrawn
- 2000-03-09 WO PCT/US2000/006058 patent/WO2000055177A2/en not_active Application Discontinuation
- 2000-03-09 JP JP2000605605A patent/JP2002538811A/ja not_active Withdrawn
- 2000-03-09 CA CA002361277A patent/CA2361277A1/en not_active Abandoned

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5536637A (en) *	1993-04-07	1996-07-16	Genetics Institute, Inc.	Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
WO1998054963A2 (en) *	1997-06-06	1998-12-10	Human Genome Sciences, Inc.	207 human secreted proteins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 18 March 1998 (1998-03-18), NATIONAL CANCER INSTITUTE: "Homo sapiens cDNA clone IMAGE:1472242 3' similar to TR:Q94532 Q94532 PUTATIVE TYPE III ALCOHOL DEHYDROGENASE", XP002234591, retrieved from EMBL SEQUENCE DATABASE Database accession no. AA873363 *

Also Published As

Publication number	Publication date
WO2000055177A2 (en)	2000-09-21
AU3396600A (en)	2000-10-04
CA2361277A1 (en)	2000-09-21
JP2002538811A (ja)	2002-11-19
EP1169332A1 (de)	2002-01-09

Publication	Publication Date	Title
EP1218408A4 (de)	2003-02-26	32 menschliche, sekretierte proteine
EP1212343A4 (de)	2004-11-03	52 menschliche sekretierte proteine
EP1181390A4 (de)	2004-08-04	27 menschliche, sekretierte proteine
EP1224285A4 (de)	2004-12-08	27 menschliche sekretierte proteine
EP1212342A4 (de)	2003-04-02	18 human-sekretierte proteine
EP1226231A4 (de)	2003-07-09	19 humane sekretierte proteine
EP1175438A4 (de)	2002-10-30	62 humane sekretierte proteine
EP1192176A4 (de)	2003-03-05	49 menschliche sekretierte proteine
EP1192278A4 (de)	2003-05-28	48 menschliche sekretierte proteine
EP1175439A4 (de)	2002-10-09	49 humane sekretierte proteine
EP1165827A4 (de)	2003-05-02	45 humane sekretierte proteine
EP1159284A4 (de)	2003-10-29	33 human sekrteierte proteine
EP1189917A4 (de)	2003-11-05	48 menschliche sekretierte proteine
EP1185543A4 (de)	2003-09-03	50 human-sekretierte proteine
EP1203005A4 (de)	2004-11-24	25 humane sekretierte proteine
EP1173477A4 (de)	2003-02-26	49 humane sekretierte Proteine
EP1224201A4 (de)	2005-03-02	32 vom menschen abgesonderte proteine
EP1206573A4 (de)	2004-08-04	26 humane sekretionsproteine
EP1169332A4 (de)	2003-09-03	49 human sekrtierte proteine
EP1171460A4 (de)	2002-10-09	48 menschliche sekretierte proteine
EP1144614A4 (de)	2003-08-06	Menschliche, ausgeschiedene proteine
EP1165602A4 (de)	2002-10-09	49 menschliche, sekretierte proteine
EP1165828A4 (de)	2002-09-25	50 menschliche sekretierte proteine
EP1228082A4 (de)	2005-11-16	29 humansekretierte proteine
EP1185285A4 (de)	2003-02-19	49 humane sekretierte proteine

Legal Events

Date	Code	Title	Description
2001-11-23	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2002-01-09	17P	Request for examination filed	Effective date: 20010912
2002-01-09	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2002-01-09	AX	Request for extension of the european patent	Free format text: AL;LT;LV;MK;RO;SI
2003-09-03	A4	Supplementary search report drawn up and despatched	Effective date: 20030717
2004-01-07	17Q	First examination report despatched	Effective date: 20031119
2004-10-22	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2004-12-08	18D	Application deemed to be withdrawn	Effective date: 20040602